Maik Brinkmann

Maik Brinkmann

Principal, Life Science Practice Group leader Asia
Patents: Life Science
Get in touch

Overview

Maik Brinkmann is the Life Science Practice Group Leader in Asia and his practice primarily involves the drafting and prosecution of patent applications, advice in relation to patent validity and enforcement, patent strategy, including global filing strategy, and patent infringement advice, predominantly in the fields of biotechnology, biochemistry, nanotechnology, process engineering and molecular biology.

Prior to joining the firm, Maik worked several years in the patent group of one of Germany’s and Singapore’s major intellectual property law firms.

Maik graduated from the Westfälische Wilhelms-University of Münster at the Institute for Chemo and Biosensoric as a Biologist (Dipl.-Biol.). His thesis was directed to the development of processes and a sensor for the detection of live pathogens in food products. During his studies he worked also at the Max-Planck-Institute for Molecular Physiology in Dortmund in the field of genetic engineering of microorganisms.

After his diploma he first continued his work at the Institute for Chemo and Biosensoric where he worked on the development of an amperometric biosensor for determining the concentration of nucleic acids. Maik changed later to the National University of Singapore, Department of Surgery, where he worked on “The experimental evaluation of a tissue engineered bone graft for cranial reconstruction”. He has special experience in the areas of molecular genetics, molecular biology and bioanalytical process engineering.

Maik is a Singapore Patent Attorney and a European Patent and Community Trade Mark Attorney, and is qualified but not presently registered as German Patent and Trade Mark Attorney. He is a member of the European Patent Institute. He is also a member of the Association of Singapore Patent Agents.

“Brinkmann draws on a breadth of experience, which includes time spent in the Max Planck Institute for Molecular Physiology and working at a major German IP law firm.”

IAM Patent 1000 – 2020 Edition – Singapore

“the best for biotech and pharma patent prosecution matters in Singapore.”

IAM Patent 1000 – 2020 Edition – Singapore

Maik Brinkmann's Insights
IPOS extends SG IP FAST Programme and ends File-To-Grant Programme
The following article provides updates on accelerated examination options in Singapore. The Intellectual Property Office of Singapore (IPOS) has recently announced that it will extend the SG IP FAST programme...
The following article provides updates on accelerated examination options in Singapore. The Intellectual Property Office of Singapore (IPOS) has recently...
Read More
Revised Patent Rules in India effective from 19 October, 2020
The India Ministry of Commerce and Industry has issued a notification that the Patents (Amendment) Rules, 2020, was released and enforced on 19 October, 2020. In summary, the key amendments...
The India Ministry of Commerce and Industry has issued a notification that the Patents (Amendment) Rules, 2020, was released...
Read More

Contact Maik Brinkmann

Would you like to join the Spruson & Ferguson team?


Work For Us

Contact our Expert Team

Contact Us